Bio-Rad Laboratories, Inc. (BIO)
USD 243.57
(4.85%)
USD 243.57
(4.85%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 12.29 Billion USD | -8.91% |
| 2022 | 13.5 Billion USD | -24.04% |
| 2021 | 17.77 Billion USD | 37.03% |
| 2020 | 12.97 Billion USD | 61.98% |
| 2019 | 8 Billion USD | 42.92% |
| 2018 | 5.6 Billion USD | 31.17% |
| 2017 | 4.27 Billion USD | 10.95% |
| 2016 | 3.85 Billion USD | 3.74% |
| 2015 | 3.71 Billion USD | 11.08% |
| 2014 | 3.34 Billion USD | -1.4% |
| 2013 | 3.38 Billion USD | -1.25% |
| 2012 | 3.43 Billion USD | 10.81% |
| 2011 | 3.09 Billion USD | 1.11% |
| 2010 | 3.06 Billion USD | 20.78% |
| 2009 | 2.53 Billion USD | 24.47% |
| 2008 | 2.03 Billion USD | 3.33% |
| 2007 | 1.97 Billion USD | 23.52% |
| 2006 | 1.59 Billion USD | 11.89% |
| 2005 | 1.42 Billion USD | 2.48% |
| 2004 | 1.39 Billion USD | 41.05% |
| 2003 | 986.85 Million USD | 36.93% |
| 2002 | 720.7 Million USD | 5.36% |
| 2001 | 684.02 Million USD | 5.84% |
| 2000 | 646.27 Million USD | -3.38% |
| 1999 | 668.9 Million USD | 82.11% |
| 1998 | 367.3 Million USD | 4.38% |
| 1997 | 351.9 Million USD | 23.52% |
| 1996 | 284.9 Million USD | -0.07% |
| 1995 | 285.1 Million USD | 8.12% |
| 1994 | 263.7 Million USD | 1.46% |
| 1993 | 259.9 Million USD | -4.69% |
| 1992 | 272.7 Million USD | 7.74% |
| 1991 | 253.1 Million USD | 18.71% |
| 1990 | 213.2 Million USD | 15.62% |
| 1989 | 184.4 Million USD | 18.74% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 9.68 Billion USD | -23.17% |
| 2024 Q3 | 10.6 Billion USD | 9.44% |
| 2024 Q1 | 12.6 Billion USD | 2.53% |
| 2023 Q1 | 13.66 Billion USD | 1.23% |
| 2023 Q4 | 12.29 Billion USD | 3.39% |
| 2023 FY | 12.29 Billion USD | -8.91% |
| 2023 Q3 | 11.89 Billion USD | -0.69% |
| 2023 Q2 | 11.97 Billion USD | -12.36% |
| 2022 Q4 | 13.5 Billion USD | 11.97% |
| 2022 Q3 | 12.05 Billion USD | -4.92% |
| 2022 Q2 | 12.68 Billion USD | -11.77% |
| 2022 Q1 | 14.37 Billion USD | -19.14% |
| 2022 FY | 13.5 Billion USD | -24.04% |
| 2021 Q4 | 17.77 Billion USD | -10.91% |
| 2021 FY | 17.77 Billion USD | 37.03% |
| 2021 Q3 | 19.95 Billion USD | 31.99% |
| 2021 Q2 | 15.11 Billion USD | 8.5% |
| 2021 Q1 | 13.93 Billion USD | 7.4% |
| 2020 FY | 12.97 Billion USD | 61.98% |
| 2020 Q1 | 8.68 Billion USD | 8.43% |
| 2020 Q2 | 10.09 Billion USD | 16.27% |
| 2020 Q3 | 12.02 Billion USD | 19.05% |
| 2020 Q4 | 12.97 Billion USD | 7.92% |
| 2019 Q3 | 7.17 Billion USD | -6.14% |
| 2019 Q4 | 8 Billion USD | 11.59% |
| 2019 Q2 | 7.64 Billion USD | 11.42% |
| 2019 FY | 8 Billion USD | 42.92% |
| 2019 Q1 | 6.86 Billion USD | 22.47% |
| 2018 FY | 5.6 Billion USD | 31.17% |
| 2018 Q4 | 5.6 Billion USD | -16.6% |
| 2018 Q3 | 6.71 Billion USD | 5.21% |
| 2018 Q2 | 6.38 Billion USD | 2.76% |
| 2018 Q1 | 6.21 Billion USD | 45.48% |
| 2017 FY | 4.27 Billion USD | 10.95% |
| 2017 Q4 | 4.27 Billion USD | 2.06% |
| 2017 Q3 | 4.18 Billion USD | 1.02% |
| 2017 Q2 | 4.14 Billion USD | 4.82% |
| 2017 Q1 | 3.95 Billion USD | 2.66% |
| 2016 FY | 3.85 Billion USD | 3.74% |
| 2016 Q3 | 4.01 Billion USD | 3.74% |
| 2016 Q4 | 3.85 Billion USD | -4.21% |
| 2016 Q2 | 3.87 Billion USD | 3.23% |
| 2016 Q1 | 3.75 Billion USD | 1.13% |
| 2015 Q2 | 3.52 Billion USD | 5.99% |
| 2015 Q3 | 3.66 Billion USD | 4.0% |
| 2015 FY | 3.71 Billion USD | 11.08% |
| 2015 Q1 | 3.32 Billion USD | -0.45% |
| 2015 Q4 | 3.71 Billion USD | 1.23% |
| 2014 Q1 | 3.44 Billion USD | 1.55% |
| 2014 Q3 | 3.38 Billion USD | -2.36% |
| 2014 Q2 | 3.46 Billion USD | 0.77% |
| 2014 FY | 3.34 Billion USD | -1.4% |
| 2014 Q4 | 3.34 Billion USD | -1.32% |
| 2013 Q2 | 3.48 Billion USD | 0.75% |
| 2013 Q4 | 3.38 Billion USD | 3.3% |
| 2013 Q3 | 3.28 Billion USD | -5.81% |
| 2013 Q1 | 3.45 Billion USD | 0.73% |
| 2013 FY | 3.38 Billion USD | -1.25% |
| 2012 FY | 3.43 Billion USD | 10.81% |
| 2012 Q1 | 3.18 Billion USD | 2.94% |
| 2012 Q2 | 3.16 Billion USD | -0.6% |
| 2012 Q3 | 3.3 Billion USD | 4.23% |
| 2012 Q4 | 3.43 Billion USD | 3.89% |
| 2011 Q1 | 2.9 Billion USD | -5.03% |
| 2011 Q2 | 3.04 Billion USD | 4.66% |
| 2011 Q3 | 2.96 Billion USD | -2.45% |
| 2011 Q4 | 3.09 Billion USD | 4.28% |
| 2011 FY | 3.09 Billion USD | 1.11% |
| 2010 Q1 | 2.54 Billion USD | 0.43% |
| 2010 FY | 3.06 Billion USD | 20.78% |
| 2010 Q4 | 3.06 Billion USD | 14.19% |
| 2010 Q3 | 2.68 Billion USD | 6.14% |
| 2010 Q2 | 2.52 Billion USD | -0.78% |
| 2009 Q2 | 2.34 Billion USD | 19.9% |
| 2009 FY | 2.53 Billion USD | 24.47% |
| 2009 Q1 | 1.95 Billion USD | -4.02% |
| 2009 Q4 | 2.53 Billion USD | 2.33% |
| 2009 Q3 | 2.47 Billion USD | 5.7% |
| 2008 Q4 | 2.03 Billion USD | 1.11% |
| 2008 Q2 | 2.09 Billion USD | 2.22% |
| 2008 Q1 | 2.05 Billion USD | 4.14% |
| 2008 FY | 2.03 Billion USD | 3.33% |
| 2008 Q3 | 2.01 Billion USD | -4.0% |
| 2007 Q3 | 1.71 Billion USD | 3.49% |
| 2007 Q4 | 1.97 Billion USD | 15.13% |
| 2007 Q1 | 1.6 Billion USD | 0.68% |
| 2007 FY | 1.97 Billion USD | 23.52% |
| 2007 Q2 | 1.65 Billion USD | 2.97% |
| 2006 Q1 | 1.41 Billion USD | -0.83% |
| 2006 FY | 1.59 Billion USD | 11.89% |
| 2006 Q2 | 1.49 Billion USD | 5.6% |
| 2006 Q3 | 1.52 Billion USD | 1.98% |
| 2006 Q4 | 1.59 Billion USD | 4.76% |
| 2005 Q2 | 1.39 Billion USD | -0.45% |
| 2005 Q3 | 1.42 Billion USD | 2.4% |
| 2005 Q4 | 1.42 Billion USD | 0.04% |
| 2005 FY | 1.42 Billion USD | 2.48% |
| 2005 Q1 | 1.39 Billion USD | 0.5% |
| 2004 Q2 | 1.02 Billion USD | 2.53% |
| 2004 Q4 | 1.39 Billion USD | 27.43% |
| 2004 FY | 1.39 Billion USD | 41.05% |
| 2004 Q1 | 997.56 Million USD | 1.08% |
| 2004 Q3 | 1.09 Billion USD | 6.81% |
| 2003 Q3 | 925.68 Million USD | 19.39% |
| 2003 FY | 986.85 Million USD | 36.93% |
| 2003 Q1 | 739.39 Million USD | 2.59% |
| 2003 Q2 | 775.37 Million USD | 4.87% |
| 2003 Q4 | 986.85 Million USD | 6.61% |
| 2002 FY | 720.7 Million USD | 5.36% |
| 2002 Q3 | 719.02 Million USD | 2.12% |
| 2002 Q4 | 720.7 Million USD | 0.23% |
| 2002 Q1 | 686.75 Million USD | 0.4% |
| 2002 Q2 | 704.12 Million USD | 2.53% |
| 2001 FY | 684.02 Million USD | 5.84% |
| 2001 Q4 | 684.02 Million USD | -0.07% |
| 2001 Q3 | 684.5 Million USD | 3.61% |
| 2001 Q2 | 660.65 Million USD | 1.5% |
| 2001 Q1 | 650.87 Million USD | 0.71% |
| 2000 Q3 | 634.16 Million USD | -4.64% |
| 2000 Q4 | 646.27 Million USD | 1.91% |
| 2000 FY | 646.27 Million USD | -3.38% |
| 2000 Q1 | 671.36 Million USD | 0.37% |
| 2000 Q2 | 665.03 Million USD | -0.94% |
| 1999 Q1 | 369.6 Million USD | 0.63% |
| 1999 Q3 | 376.1 Million USD | 1.29% |
| 1999 Q4 | 668.9 Million USD | 77.85% |
| 1999 Q2 | 371.3 Million USD | 0.46% |
| 1999 FY | 668.9 Million USD | 82.11% |
| 1998 Q2 | 370.3 Million USD | 0.19% |
| 1998 Q4 | 367.3 Million USD | 1.58% |
| 1998 FY | 367.3 Million USD | 4.38% |
| 1998 Q1 | 369.6 Million USD | 5.03% |
| 1998 Q3 | 361.6 Million USD | -2.35% |
| 1997 Q4 | 351.9 Million USD | 17.34% |
| 1997 Q1 | 291.8 Million USD | 2.42% |
| 1997 Q2 | 292.1 Million USD | 0.1% |
| 1997 Q3 | 299.9 Million USD | 2.67% |
| 1997 FY | 351.9 Million USD | 23.52% |
| 1996 Q1 | 291.5 Million USD | 2.24% |
| 1996 Q2 | 290.9 Million USD | -0.21% |
| 1996 Q3 | 290.8 Million USD | -0.03% |
| 1996 Q4 | 284.9 Million USD | -2.03% |
| 1996 FY | 284.9 Million USD | -0.07% |
| 1995 FY | 285.1 Million USD | 8.12% |
| 1995 Q1 | 284.1 Million USD | 7.74% |
| 1995 Q2 | 285.8 Million USD | 0.6% |
| 1995 Q3 | 281.8 Million USD | -1.4% |
| 1995 Q4 | 285.1 Million USD | 1.17% |
| 1994 Q2 | 266.1 Million USD | -0.08% |
| 1994 Q4 | 263.7 Million USD | -0.08% |
| 1994 FY | 263.7 Million USD | 1.46% |
| 1994 Q1 | 266.3 Million USD | 2.46% |
| 1994 Q3 | 263.9 Million USD | -0.83% |
| 1993 Q1 | 280.8 Million USD | 2.97% |
| 1993 Q2 | 283.6 Million USD | 1.0% |
| 1993 Q3 | 274.5 Million USD | -3.21% |
| 1993 Q4 | 259.9 Million USD | -5.32% |
| 1993 FY | 259.9 Million USD | -4.69% |
| 1992 Q4 | 272.7 Million USD | -0.73% |
| 1992 FY | 272.7 Million USD | 7.74% |
| 1992 Q1 | 259.8 Million USD | 2.65% |
| 1992 Q2 | 296 Million USD | 13.93% |
| 1992 Q3 | 274.7 Million USD | -7.2% |
| 1991 Q4 | 253.1 Million USD | 5.94% |
| 1991 Q1 | 222.5 Million USD | 4.36% |
| 1991 Q2 | 225.2 Million USD | 1.21% |
| 1991 Q3 | 238.9 Million USD | 6.08% |
| 1991 FY | 253.1 Million USD | 18.71% |
| 1990 FY | 213.2 Million USD | 15.62% |
| 1990 Q2 | 197 Million USD | 2.82% |
| 1990 Q3 | 200.7 Million USD | 1.88% |
| 1990 Q4 | 213.2 Million USD | 6.23% |
| 1990 Q1 | 191.6 Million USD | 3.9% |
| 1989 FY | 184.4 Million USD | 18.74% |
| 1989 Q4 | 184.4 Million USD | 4.83% |
| 1989 Q3 | 175.9 Million USD | 2.15% |
| 1989 Q2 | 172.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 83.201% |
| Allurion Technologies Inc. | 71.71 Million USD | -17050.644% |
| Artivion, Inc. | 792.39 Million USD | -1452.135% |
| Avanos Medical, Inc. | 1.69 Billion USD | -626.724% |
| Butterfly Network, Inc. | 304.27 Million USD | -3942.103% |
| Butterfly Network, Inc. | 304.27 Million USD | -3942.103% |
| Boston Scientific Corporation | 35.13 Billion USD | 64.996% |
| CONMED Corporation | 2.3 Billion USD | -434.737% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | -31.355% |
| Paragon 28, Inc. | 340.69 Million USD | -3509.952% |
| Glaukos Corporation | 940.41 Million USD | -1207.836% |
| Globus Medical, Inc. | 5.08 Billion USD | -141.818% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -1717.209% |
| Integer Holdings Corporation | 2.94 Billion USD | -317.959% |
| Medtronic plc | 89.98 Billion USD | 86.331% |
| Myomo, Inc. | 14.58 Million USD | -84246.69% |
| Nevro Corp. | 635.71 Million USD | -1834.689% |
| Owlet, Inc. | 44.12 Million USD | -27774.51% |
| Penumbra, Inc. | 1.55 Billion USD | -690.274% |
| Vicarious Surgical Inc. | 119.86 Million USD | -10160.854% |
| Smith & Nephew plc | 9.98 Billion USD | -23.151% |
| Sonendo, Inc. | 78.16 Million USD | -15635.76% |
| STERIS plc | 11.06 Billion USD | -11.166% |
| Stryker Corporation | 39.91 Billion USD | 69.185% |
| Vapotherm, Inc. | 77.61 Million USD | -15745.846% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 42.787% |